Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 34,564 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 1.08 | Mínimo Máximo |
|||||
| Minimo del Dia | 1.02 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| INVO BioScience Inc | INVO | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.011 | -1.04% | 1.049 | 10:29:52 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1.05 | 1.02 | 1.08 | 1.06 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 221 | 34,564 | US$ 1.03 | US$ 35,708 | - | 0.50 - 10.498 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 10:40:54 | 20 | US$ 1.0302 | USD |
Información Financiera INVO BioScience Inc INVO
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 2.57M | 2.47M | - | 3.02M | -8.04M | -3.25 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre INVO BioScience Inc INVO
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 17/4/2024 | 09:25 | AllPennyStocks.com | Micro Cap Massively Bid Up Before Opening Bell |
| 16/4/2024 | 15:59 | GlobeNewswire Inc. | INVO Reports Fourth Quarter and Full Year 2023 Financial.. |
| 06/2/2024 | 09:24 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 01/2/2024 | 08:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23/1/2024 | 07:00 | GlobeNewswire Inc. | NAYA Biosciences To Acquire Clinical Stage Gene Therapy.. |
| 17/1/2024 | 07:00 | GlobeNewswire Inc. | INVO Bioscience Files S-4 Registration and Preliminary Joint.. |
| 16/1/2024 | 16:29 | Edgar (US Regulatory) | Form S-4 - Registration of securities, business combinations |
| 10/1/2024 | 15:46 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 10/1/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 03/1/2024 | 16:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28/12/2023 | 16:04 | Edgar (US Regulatory) | Form 424B7 - Prospectus [Rule 424(b)(7)] |
| 28/12/2023 | 16:02 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos INVO
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.46 | 0.8901 | 1.12 | 446,410 | -0.151 | -12.58% |
| 1 Month | 1.01 | 3.50 | 0.70 | 1.79 | 11,962,762 | 0.039 | 3.86% |
| 3 Months | 0.90 | 3.50 | 0.70 | 1.79 | 4,139,393 | 0.149 | 16.56% |
| 6 Months | 1.24 | 3.50 | 0.629999 | 1.70 | 3,000,769 | -0.191 | -15.40% |
| 1 Year | 7.202 | 10.498 | 0.50 | 2.23 | 2,369,610 | -6.15 | -85.43% |
| 3 Years | 84.40 | 108.552 | 0.50 | 3.89 | 827,829 | -83.35 | -98.76% |
| 5 Years | 63.40 | 246.00 | 0.50 | 31.22 | 864,596 | -62.35 | -98.35% |
